|
Fischer Medical Ventures’ sister concern Nanyang Biologics (NYB) enters a strategic collaboration with Nvidia, Hewlett Packard Enterprise (HPE), and Equinix to build Vecura—an AI-powered drug discovery platform that combines advanced predictive models with a proprietary library of millions of natural compounds. Through this initiative, NYB aims to accelerate the development of next-generation health solutions across pharmaceuticals, dietary supplements, functional foods, and personal care. Designed as an “AI-as-a-Service” platform, Vecura seeks to reduce the therapeutic drug discovery timeline from the traditional 10–12 years to just few hours!
The signing event marked the beginning of the collaboration with world renowned heavyweight company Nvidia, HPE, and Equinix, to co-develop what will become a world-largest AI-curated compound library, anchored in Singapore.
Traditional drug discovery is often slow, costly, and inefficient, hindering the development of life-saving therapeutics. NYB’s Vecura seeks to transform this landscape by harnessing advanced technologies such as AI, machine learning, and virtual screening. Through curating a vast Natural Compound Library from tropical flora, and integrating cutting-edge metagenomics and metaproteomics analysis, Vecura can uncover the therapeutic potential hidden within diverse plants swiftly, enables rapid identification of promising drug candidates, significantly reducing discovery time and costs while opening new frontiers in personalized medicine and nature-based therapeutics.
Beyond drug discovery, NYB is harnessing its AI-powered discovery platform and vast, biodiverse compound library to build a pipeline of evidence-based nutraceuticals designed to enhance human resilience, restore metabolic balance, and promote long-term vitality. At the forefront of this initiative is CareViva NS, a longevity-focused formulation derived from traditional herbs and worked on by more than 26 scientists & professors from the prestigious Nanyang Technological University of Singapore.
Ravindran Govindan, executive chairman & MD of FMV, said “With the strong support of world-class companies like Nvidia, HPE and Equinix, NYB’s supercharged Vecura platform will unleash powerful therapeutic potential of nature with AI and discover millions of valuable natural compounds in shorter time to enable any Biotech companies to use to develop their health and wellness products faster.”
|